Learn more about whether IDEAYA Biosciences, Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Catalyst Pharmaceuticals, Inc. or IDEAYA Biosciences, Inc. is a better investment based on AAII's A+ ...
Living with prostate cancer can be very stressful. It can affect a person’s body, life plans, relationships, and emotions. Many people don’t realize that people with prostate cancer are at risk for ...
Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...
In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don ...
A new strategy developed by Professor Nathan Gianneschi grabs cancer-driving proteins and directs them to the cell’s disposal ...
Actinium-225 is a targeted and highly-potent alpha emitter that holds promise for patients who do not respond to lutetium-177 ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results